We are live on ! Find out more
TSRX

TRIUS THERAPEUTICS INC COM STK (DE)
TSRX

Delisted

TSRX was delisted on the 11th of September, 2013.

1 hedge funds and large institutions have $54K invested in TRIUS THERAPEUTICS INC COM STK (DE) in 2013 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

86% less funds holding

Funds holding: 71 (-6)

90% less capital invested

Capital invested by funds: $529K → $54K (-$475K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 6

Holders
1
Holders Change
-6
Holders Change %
-85.71%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
6
Calls
Puts
Net Calls
Net Calls Change

TSRX Hedge Fund Activity: Q4 2013 in Review

1 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) for Q4 2013, worth a combined $54K — down 90% from $529K a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TSRX and 0 opened new positions — a net loss of 6 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Panagora Asset Management, exiting entirely with an estimated $139K sold.

  • 1 institutional investor held TRIUS THERAPEUTICS INC COM STK (DE) (TSRX) as of Q4 2013, down from 7 in Q3 2013.
  • Funds reported $54K of TRIUS THERAPEUTICS INC COM STK (DE) stock for Q4 2013, down 90% quarter-over-quarter.
  • 0 funds opened new TRIUS THERAPEUTICS INC COM STK (DE) positions in Q4 2013 and 6 closed out, a net change of -6 holders.
  • The largest TRIUS THERAPEUTICS INC COM STK (DE) seller in Q4 2013 was Panagora Asset Management, an estimated $139K sold.

Based on aggregated 13F filings for Q4 2013.